Treatment outcome analysis of bevacizumab combined with cyclophosphamide and oxaliplatin in advanced pseudomyxoma peritonei

BACKGROUND: Pseudomyxoma peritonei (PMP) is a rare peritoneal malignant tumor syndrome. Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy is its standard treatment. However, there are few studies and insufficient evidence regarding systemic chemotherapy of advanced PMP. R...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ying, Zhao, Xin, Gao, Chao, Lin, Lin-Yu, Li, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315110/
https://www.ncbi.nlm.nih.gov/pubmed/37405093
http://dx.doi.org/10.4240/wjgs.v15.i6.1149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315110/
https://www.ncbi.nlm.nih.gov/pubmed/37405093
http://dx.doi.org/10.4240/wjgs.v15.i6.1149

Ejemplares similares